Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sugar Watchers is a health-focused food company specializing in low Glycemic Index (GI) staples designed for diabetes and weight management. The company offers a range of products including low GI rice, atta (flour), and poha that are clinically tested to help manage blood sugar levels without requiring significant dietary changes. By replacing standard high-carb staples with low GI alternatives, Sugar Watchers aims to provide a sustainable nutritional intervention for individuals with prediabetes, diabetes, and PCOS. Their products are widely available through e-commerce platforms and retail outlets in India. The company leverages natural processing techniques to maintain the nutritional integrity of grains while lowering their glycemic impact.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sugar Watchers Low GI Staples.